Francisco Arias-Mora

Francisco Arias-Mora

Auto-generated profile, based on publicly available information

Francisco Arias-Mora

Neurology Department, Fundación Valle del Lili Hospital Universitario, Cali, Colombia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2021 in Case Reports in Cardiology
Verified
Journal Article
Open access
PDF file
JRJulián Alejandro Rivillas
Julián Alejandro Rivillas
SGStephania Galindo-Coral
Stephania Galindo-Coral
FAFrancisco Arias-Mora
Francisco Arias-Mora
JLJuan David Lopez
Juan David Lopez
NFNoel Alberto Florez-Alarcón
Noel Alberto Florez-Alarcón
JGJuan Esteban Gómez-Mesa
Juan Esteban Gómez-Mesa
Background. Neurological complications occur between 50 and 70% of patients with heart transplantation, including cerebrovascular events, infections, seizures, encephalopathy, and neurotoxicity due to pharmacological immunosuppression. Mortality associated with cerebrovascular complications is 7.5% in the first 30 days and up to 5.3% after the first month and up to the first year after transplantation. Case Reports. Three heart-transplanted patients (2 men and 1 woman) treated with tacrolimus were identified. They presented with posterior reversible encephalopathy syndrome on days 5, 6, and 58 posttransplantation, respectively. In these reported cases, no sequelae were observed at 6 months follow-up. Conclusions. Posterior reversible encephalopathy syndrome as a neurological complication in patients with HT occurred early after the procedure. Early diagnosis and treatment might reduce the risk of serious complications and mortality.